Idexx Laboratories (IDXX) remains a strong growth stock for both momentum and long-term investments. The company recently broke out above the 20-Day moving average. Analyst upgrades and the strong momentum have shaped its current valuation. Over the past ten years, an investment of $1000 in Idexx would have yielded substantial returns, underscoring the company's steady and robust performance. Highlights from Q2 2025 earnings call indicate strong revenue and EPS growth, with the company's earnings outperforming last year's by 16%. The stock has seen bullish momentum informed by a KDJ Golden Cross and a Bullish Marubozu on the 15min chart. Despite some cautious technicals, Idexx continues to demonstrate strong fundamentals, buoyed by strategic innovation in Veterinary Diagnostics, robust CAG Diagnostics Business, and Cloud-Based Products. Still, investors need to be wary of Idexx insiders selling a significant portion of their shares which could signal caution.
Idexx Laboratories IDXX News Analytics from Mon, 03 Feb 2025 08:00:00 GMT to Sat, 30 Aug 2025 15:25:40 GMT -
Rating 7
- Innovation 7
- Information 9
- Rumor 2
